References
- Dispenzieri A, Kyle RA, Lacy MQ, Rajkumar SV, Themeau TM, Larson DR, Greipp PR, Witzig TE, Basu R, Suarez GA, Fonseca R, Lust JA, Gertz MA. POEMS syndrome: Definitions and long-term outcome. Blood 2003;101(7):2496–2506.
- Kyle RA, Dyck PJ. Osteosclerotic myeloma. In: Saunders WB, editor. Peripheral neuropathies. 3rd ed. Philadelphia/London. 1992;2(68): 1288–1293.
- Jaccard A, Royer B, Bordessoule D, Brouet JC, Fermand JP. High-dose therapy and autologous blood stem cell transplan-tation in POEMS syndrome. Blood 2002;99(8):3057–3059.
- Dispenzieri A, Moreno-Aspitia A, Suarez GA, Lacy MQ, Colon-Otero G, Tefferi A, Litzow MR, Roy V, Hogan WJ, Kyle RA, Gertz MA. Peripheral blood stem cell transplantation in 16 patients with POEMS syndrome, and a review of the literature. Blood 2004;104(10):3400–3407.
- Wiesmann A, Weissert R, Kanz L, Einsele H. Long-term follow-up on a patient with incomplete POEMS syndrome undergoing high-dose therapy and autologous blood stern cell transplantation. Blood 2002;100(7):2679–2680.
- Kuwabara S, Misawa S, Kanai K, Kikkawa Y, Nishimura M, Nakaesko C, Cho RK, Hattori T. Autologous peripheral blood stem cell transplantation for POEMS syndrome. Neurology 2006;66(1):105–107.
- Anal M, Harousseau JI,, Stoppa AM, Sotto JJ, Fuzibet JG, Rossi JF, Casassus P, Maisonneuve H, Facon T, Ifrah N, Payen C, Bataille R. A prospective, randomized trial of autologous transplantation and chemotherapy in multiple myeloma. N Engl J Med 1996;335(2):91–97.
- Child JA, Morgan GJ, Davies FE, Owen RG, Bell SE, Hawkins K, Brown J, Drayson MT, Selby PJ. High dose chemotherapy with hematopoietic stem cell rescue for multiple myeloma. N Engl J Med 2003;348(19):1875–1883.
- Hitoshi S, Suzuki K, Sakuta M. Elevated serum interleukin-6 in POEMS syndrome reflects the activity of the disease. Intern Med 1994;33(10):582–587.
- Dispenzieri A, Kyle RA. Neurological aspects of multiple myeloma and related disorders. Best Pract Res Clin Haematol 2005;18(4):673–688.
- Saunders G. Overview of drug therapy for multiple myeloma. J Oncol Pharm Pract 2005;11(3):83–100.